Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
Iran J Vet Res ; 22(3): 195-202, 2021.
Article in English | MEDLINE | ID: mdl-34777519

ABSTRACT

BACKGROUND: Citral (C10H16O) is the main ingredient of Cymbopogon citratus (lemongrass oil) and can reduce the side effects of oxidative stress. Diabetes caused by insulin deficiency induces oxidative stress in the liver. AIMS: This study aimed to investigate the ameliorative effects of citral on selected oxidative parameters and the gene expression of paraoxonase 1 (PON1) and endothelial nitric oxide synthase (eNOS) in a rat model of streptozotocin (STZ)-induced diabetes mellitus. METHODS: Forty rats were divided into four groups at random: control (C), control citral (CC), and two STZ-induced diabetic groups (diabetic (D) and citral diabetic (CD)). After diabetes confirmation (day 7), gavage treatment with citral (300 mg/kg body weight (BW)) was started in the CD and CC groups and continued for two weeks. RESULTS: On day 21 of the study, following treatment with citral for 14 days, the serum levels of total antioxidant capacity (TAC), and PON1 in the CD group were significantly increased compared to those in the D group (P<0.05). While treatment with citral caused a significant decrease in the Malondialdehyde (MDA), and eNOS in the CD group compared to those of the D group (P<0.001). The expression rate of liver PON1 gene was considerably upregulated in the CD group compared to that in the D group (P<0.001); while the opposite was observed for eNOS gene expression. However, there was no significant difference between the CC and C groups in terms of all examined parameters (P>0.05). CONCLUSION: This study showed positive effects of citral on serum antioxidant status and liver gene expression of PON1 and eNOS in diabetic rats.

2.
J Appl Microbiol ; 131(4): 2033-2048, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33719123

ABSTRACT

AIMS: Present study was aimed to determine ESBL-encoding genes distribution in Diarrhoeagenic Escherichia coli (DEC) isolated from animal-source food products and human clinical samples in Mashhad, Iran. The strains were also further studied to analyse genotypic diversity and find genetic relationships between them. METHODS AND RESULTS: The number of 85 DEC strains including 52 and 33 strains isolated from 300 food and 520 human stool samples, respectively. Randomly amplified polymorphic DNA (RAPD), and repetitive extragenic palindromic-PCR (rep-PCR) typing methods were used to track their genetic relationships. The ESBL-encoding genes prevalence was approximately 70% in both groups of isolates. The blaTEM , blaCTX-M and blaSHV were prevalent in 67·1, 20 and 10·6% of isolates, respectively. The ESBL-positives showed significantly higher resistance rates to gentamicin, co-trimoxazole, tetracycline, aztreonam and chloramphenicol (P < 0·05). Fingerprinting patterns-based dendrograms divided DEC strains into separate clusters irrespective of their sources and pathotypes. In typing field, rep-PCR provided more discriminatory power (Simpson's index of diversity (SID) = 0·925) than RAPD (SID = 0·812). CONCLUSION: Molecular similarity between certain animal-sourced food products and clinical sample strains supported food-borne transmission routes for genotypic elements such as ESBL-encoding genes. SIGNIFICANCE AND IMPACT OF THE STUDY: Findings emphasize the importance of resistance issues, the need to improve treatment guidelines and routine surveillance of hygienic measures during food processing.


Subject(s)
Escherichia coli Infections , beta-Lactamases , Animals , Anti-Bacterial Agents/pharmacology , Escherichia coli/genetics , Escherichia coli Infections/epidemiology , Humans , Iran/epidemiology , Molecular Typing , Prevalence , Random Amplified Polymorphic DNA Technique , beta-Lactamases/genetics
3.
J Appl Microbiol ; 131(1): 449-459, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33058340

ABSTRACT

AIMS: This study aimed to evaluate the effects of three Bacillus probiotics on Salmonella Typhimurium, and interleukin-8 (IL-8) gene expression in the co-culture of the Bacillus and the pathogen in vitro. METHODS AND RESULTS: Bacillus subtilis, Bacillus indicus and Bacillus coagulans were initially turned to spore and heat-inactivated forms. The cellular damages of the probiotics on the HT-29 cells were investigated individually and in combination with S. Typhimurium using 3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and fluorescence assays. To extract cell free supernatants (CFS) of the probiotics, they were cultured in selective media. The inhibitory activity of CFSs were then assayed against the pathogen. The gene expression of IL-8 of the HT-29 cells was evaluated by real-time PCR in all the groups. The results showed that the CFSs of three probiotics could inhibit the growth of S. Typhimurium by more than 50%. Inhibitory effects of B. indicus and B. subtilis CFSs were related to the production of pepsin-sensitive compounds, except B. coagulans in which the high inhibitory effect was due to organic acids. The spores of the three probiotics and the heat-inactivated forms of B. subtilis and B. coagulans could reduce the cytotoxicity of S. Typhimurium. The cell viability also increased applying both forms probiotics against the pathogen. In all co-culture groups, the IL-8 gene expression induced by S. Typhimurium was reduced. CONCLUSIONS: The three Bacillus probiotics can be considered as proper candidates for the prevention and treatment of S. Typhimurium food poisoning. SIGNIFICANCE AND IMPACT OF THE STUDY: Applying probiotics as live bacteria is universally noted in foods. This study tried to discover the effects of Bacillus probiotics in the form of spore or even heat-killed bacteria against S. Typhimurium and evaluate ratio of IL-8 gene expression in cell culture. The most effective Bacillus probiotic will be recommended. This approach will help to use probiotics as nonvegetative cells in foods to fight gastrointestinal pathogens.


Subject(s)
Apoptosis/drug effects , Bacillus/physiology , Interleukin-8/genetics , Probiotics/pharmacology , Salmonella typhimurium/drug effects , Bacillus/classification , Epithelial Cells/metabolism , Epithelial Cells/microbiology , Gene Expression/drug effects , HT29 Cells , Humans , Interleukin-8/metabolism , Salmonella typhimurium/growth & development , Salmonella typhimurium/pathogenicity , Spores, Fungal/classification , Spores, Fungal/physiology
4.
J Dent Res ; 98(9): 985-993, 2019 08.
Article in English | MEDLINE | ID: mdl-31226001

ABSTRACT

Chronic periodontitis (ChP) is a prevalent inflammatory disease affecting 46% of the US population. ChP produces a profound local inflammatory response to dysbiotic oral microbiota that leads to destruction of alveolar bone and tooth loss. ChP is also associated with systemic illnesses, including cardiovascular diseases, malignancies, and adverse pregnancy outcomes. However, the mechanisms underlying these adverse health outcomes are poorly understood. In this prospective cohort study, we used a highly multiplex mass cytometry immunoassay to perform an in-depth analysis of the systemic consequences of ChP in patients before (n = 28) and after (n = 16) periodontal treatment. A high-dimensional analysis of intracellular signaling networks revealed immune system-wide dysfunctions differentiating patients with ChP from healthy controls. Notably, we observed exaggerated proinflammatory responses to Porphyromonas gingivalis-derived lipopolysaccharide in circulating neutrophils and monocytes from patients with ChP. Simultaneously, natural killer cell responses to inflammatory cytokines were attenuated. Importantly, the immune alterations associated with ChP were no longer detectable 3 wk after periodontal treatment. Our findings demarcate systemic and cell-specific immune dysfunctions in patients with ChP, which can be temporarily reversed by the local treatment of ChP. Future studies in larger cohorts are needed to test the boundaries of generalizability of our results.


Subject(s)
Chronic Periodontitis/immunology , Killer Cells, Natural/immunology , Monocytes/immunology , Neutrophils/immunology , Adult , Cytokines/immunology , Female , Humans , Male , Middle Aged , Porphyromonas gingivalis , Prospective Studies
5.
East Mediterr Health J ; 19 Suppl 3: S194-7, 2014 Jan 09.
Article in English | MEDLINE | ID: mdl-24995747

ABSTRACT

It is sometimes difficult to insert a nasogastric tube in an anaesthetized patient. We evaluated the benefit of reinforcing the distal portion of the nasogastric tube with a Nelaton catheter: 8 and 10 French Nelaton catheters were inserted into 16 and 18 French nasogastric tubes respectively through the first proximal holes of tubes up to their tips. The patients anaesthetized were randomly allocated into either the control or the Nelaton groups, and nasogastric tube was inserted as deeply as the catheter length, then the catheter was withdrawn and the tube was inserted farther to reach the stomach. Eighty patients (40 in each group) were included in this study. The success rate of nasogastric tube insertion was 90% in the Nelaton group and 57% in the control group (P = 0.001). The mean insertion time was 80 (SD 43) and 92 (SD 35) seconds in the Nelaton and the control groups respectively.

6.
(East. Mediterr. health j).
in English | WHO IRIS | ID: who-118610

ABSTRACT

It is sometimes difficult to insert a nasogastric tube in an anaesthetized patient. We evaluated the benefit of reinforcing the distal portion of the nasogastric tube with a Nelaton catheter: 8 and 10 French Nelaton catheters were inserted into 16 and 18 French nasogastric tubes respectively through the first proximal holes of tubes up to their tips. The patients anaesthetized were randomly allocated into either the control or the Nelaton groups, and nasogastric tube was inserted as deeply as the catheter length, then the catheter was withdrawn and the tube was inserted farther to reach the stomach. Eighty patients [40 in each group] were included in this study. The success rate of nasogastric tube insertion was 90% in the Nelaton group and 57% in the control group [P = 0.001]. The mean insertion time was 80 [SD 43] and 92 [SD 35] seconds in the Nelaton and the control groups respectively

7.
Thorac Cardiovasc Surg ; 59(2): 108-14, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21384307

ABSTRACT

BACKGROUND: In the last 30 years lung transplantation has proven to be a lifesaving therapeutic option for patients with end-stage lung disease. The objective of this study was to perform a bibliometric analysis of lung transplantation research articles. METHOD: A bibliometric evaluation of the evolution of scientific production in the field of lung transplantations between 1989 and 2009 was conducted using the ISI Web of Science. The search terms selected were "lung transplant" OR "pulmonary transplant". Specific features including year of publication, language, geographical distribution, first author, main journal publishing these articles, journals publishing highly cited articles, and institutional affiliation were analyzed. The citation characteristics of articles were additionally analyzed. RESULTS: A total of 6409 (58.0 %) research articles were found. The time trend of the number of articles showed an increase of more than 6.81 between 1989 and 2009. North America contributed 50.4 % and Europe contributed 46.0 % of published articles. The greatest number of contributions came from the USA (43.6 %), followed by England (9.1 %) and Germany (8.6 %). There were 104 522 citations of these articles by 25 July 2010. The average citation per article was 16.31. The New England Journal of Medicine ranked first with regard to the number of articles and the number of highly cited articles. G. A. Patterson, Washington University, and the US National Institutes of Health (NIH) were the top author, institution and funding agency, respectively. CONCLUSION: The number of publications and the scientific interest in lung transplantation has increased rapidly in recent years. Citations of articles published in the field of lung transplantation are increasing and the numbers of uncited articles are fewer compared to the average citations of articles and uncited articles in the field of medicine.


Subject(s)
Biomedical Research/statistics & numerical data , Lung Transplantation/statistics & numerical data , Periodicals as Topic/statistics & numerical data , Academies and Institutes/statistics & numerical data , Authorship , Bibliometrics , Databases, Bibliographic , Humans , Language , Time Factors
9.
Eur J Neurol ; 9(6): 671-7, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12453084

ABSTRACT

This paper compares the results of parallel positron emission tomography (PET) studies of regional cerebral glucose metabolism with the radiotracer 18F-fluorodeoxyglucose (FDG) and benzodiazepine receptor (BZR) density by PET using the BZR ligand 11C-flumazenil (FMZ), a tracer of neuronal integrity, in nine patients with acute vegetative state (AVS, duration <1 month). Overall glucose utilization was significantly reduced in AVS in comparison with age-matched controls (global metabolic rate for glucose 26 micromol/100 g/min in AVS vs. 31 micromol/100 g/min in controls). FMZ-PET demonstrated a considerable reduction of BZR binding sites in all cortical regions that grossly corresponded to the extent of reduction of cerebral glucose metabolism assessed with FDG-PET, whilst the cerebellum was spared from neuronal loss. In controls, cortical relative flumazenil binding was not lower than five times the average white matter activity, whilst in AVS, nearly all values were below this threshold. There was no relevant overlap of the data of relative flumazenil binding between both groups. The comparison of FDG- and FMZ-PET findings in AVS demonstrates that alterations of cerebral glucose consumption do not represent mere functional inactivation, but irreversible structural brain damage.


Subject(s)
Brain/metabolism , Glucose/metabolism , Persistent Vegetative State/metabolism , Receptors, GABA-A/metabolism , Acute Disease , Aged , Binding Sites , Carbon Radioisotopes , Control Groups , Female , Flumazenil/pharmacokinetics , Fluorodeoxyglucose F18 , GABA Modulators/pharmacokinetics , Humans , Male , Middle Aged , Persistent Vegetative State/diagnostic imaging , Radiopharmaceuticals , Tomography, Emission-Computed
10.
J Neurol Neurosurg Psychiatry ; 73(5): 517-23, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12397143

ABSTRACT

OBJECTIVES: The differential diagnosis between typical idiopathic Parkinson's disease (PD) and the striatonigral variant of multiple system atrophy (MSA-P) is often difficult because of the presence of signs and symptoms common to both forms of parkinsonism, particularly at symptom onset. This study investigated striatal and midbrain findings in MSA-P and PD patients in comparison with normal controls with the use of positron emission tomography (PET) and three dimensional magnetic resonance imaging (3D MRI) based volumetry to increase the differential diagnostic accuracy between both disease entities. METHODS: Nine patients with MSA-P, 24 patients with PD, and seven healthy controls were studied by MRI and PET with 6-[(18)F]-fluoro-L-dopa (FDOPA), [(18)F]fluoro-deoxyglucose (FDG), and 11-C-Raclopride (RACLO). Striatal and extrastriatal volumes of interest (VOI) were calculated on the basis of the individual MRI data. The PET data were transferred to the VOI datasets and subsequently analysed. RESULTS: MSA-P differed significantly from PD patients in terms of decreased putaminal volume, glucose metabolism, and postsynaptic D2 receptor density. The striatal FDOPA uptake was equally impaired in both conditions. Neither MRI volumetry nor PET imaging of the midbrain region further contributed to the differential diagnosis between PD and MSA-P. CONCLUSIONS: The extent and spatial distribution of functional and morphological changes in the striatum permit the differentiation of MSA-P from PD. Both, multi-tracer PET and 3D MRI based volumetry, may be considered equivalent in the assessment of different striatal abnormality in both disease entities. In contrast, MRI and PET imaging of the midbrain does not provide a further gain in diagnostic accuracy.


Subject(s)
Corpus Striatum/metabolism , Corpus Striatum/pathology , Magnetic Resonance Imaging , Mesencephalon/metabolism , Mesencephalon/pathology , Parkinson Disease/diagnosis , Tomography, Emission-Computed , Atrophy/pathology , Diagnosis, Differential , Female , Fluorodeoxyglucose F18 , Humans , Male , Middle Aged , Putamen/metabolism , Putamen/pathology , Radiopharmaceuticals
11.
J Neural Transm (Vienna) ; 109(10): 1257-64, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12373559

ABSTRACT

In order to compare the effects of high-frequency stimulation of the subthalamic nucleus (STN-DBS) and a levodopa-challenge on cerebral metabolic activity, we conducted PET scans with [(18)F]2-fluoro-2-deoxyglucose (FDG) in the drug- and stimulation- on- and off-condition in a single patient suffering from advanced PD. Our data revealed evidence for improved thalamocortical processing released from inhibition by overactive basal ganglia output nuclei in both on-conditions. While levodopa also led to a reduction of lentiform hyperactivity, effective STN stimulation seemed to interfere with distinct cerebellar and limbic circuits.


Subject(s)
Antiparkinson Agents/therapeutic use , Electric Stimulation Therapy , Levodopa/therapeutic use , Parkinson Disease/drug therapy , Parkinson Disease/therapy , Subthalamic Nucleus/physiology , Aged , Brain Chemistry/physiology , Brain Chemistry/radiation effects , Fluorodeoxyglucose F18 , Functional Laterality/physiology , Gait/physiology , Glucose/metabolism , Humans , Male , Parkinson Disease/diagnostic imaging , Radiopharmaceuticals , Subthalamic Nucleus/diagnostic imaging , Subthalamic Nucleus/metabolism , Tomography, Emission-Computed
12.
Ann Neurol ; 50(5): 620-9, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11706968

ABSTRACT

We investigated plasticity of language networks exposed to slowly evolving brain damage. Single subject 0-15-water language activation positron emission tomography studies were analyzed in 61 right-handed patients with brain tumors of the left hemisphere, and 12 normal controls. In controls, activations were found in left Brodmann's Area (BA)44 and BA45, superior posterior temporal gyrus bilaterally, and right cerebellum. Patients additionally activated left BA46, BA47, anterior insula, and left cerebellum. Superior temporal activation was less frequent, and activations in areas other than posterior temporal gyrus were found bilaterally. Frontolateral activations within the nondominant hemisphere were only seen in patients (63%) with frontal or posterior temporal lesions. Laterality indices of frontolateral cortex showed reversed language dominance in 18% of patients. Laterality indices of the cerebellum were negatively correlated with language performance. Two compensatory mechanisms in patients with slowly evolving brain lesions are described: An intrahemispheric mechanism with recruitment of left frontolateral regions other than classic language areas; and an interhemispheric compensatory mechanism with frontolateral activation in the nondominant hemisphere. The latter one was only found in patients with frontal or posterior temporal lesions, thus supporting the hypothesis that right frontolateral activations are a disinhibition phenomenon.


Subject(s)
Brain Neoplasms/physiopathology , Brain/physiopathology , Glioma/physiopathology , Language Tests , Nerve Net/diagnostic imaging , Nerve Net/physiopathology , Neuronal Plasticity , Adult , Brain/diagnostic imaging , Brain/pathology , Chronic Disease , Dominance, Cerebral , Female , Functional Laterality , Humans , Male , Tomography, Emission-Computed
13.
J Neurol Neurosurg Psychiatry ; 71(2): 193-9, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11459891

ABSTRACT

OBJECTIVES: The advent of botulinum neurotoxin type A (BoNT/A) gave rise to substantial progress in the treatment of focal dystonias. In the light of the high costs of the toxin and the necessity to establish valid outcome indices for this treatment apart from sheer reduction of dystonic muscle tone and posture, the impact of focal dystonia and its treatment with BoNT/A on patients' health related quality of life (HRQL) was determined. METHODS: Fifty patients with cranial and cervical dystonia treated long term with BoNT/A were enrolled in a prospective, open labelled cohort study. The HRQL was assessed using the EuroQol (EQ-5D) and the short form 36 health survey questionnaire (SF-36) at baseline before BoNT/A injections and at two follow up visits after 6 and 12 weeks covering one BoNT/A treatment period with maximum effect size at the first follow up. RESULTS: Compared with a general population sample, a considerable negative impact of focal dystonia on HRQL was found in patients under investigation. In both disease types, BoNT/A treatment led to a significant improvement in several HRQL dimensions, in particular providing moderate to marked effect sizes in the fields of mental health and pain. The impairment of HRQL due to pain as well as the BoNT/A induced improvement within this SF-36 subscore were significantly higher in patients with cervical dystonia. Under BoNT/A therapy, no correlation was found between changes of clinical outcome scores and HRQL measures. CONCLUSIONS: The data confirm that BoNT/A is able to induce a significant, but temporary amelioration of several aspects of HRQL in both types of focal dystonia. This may substantially contribute to the patients' subjective benefit from the therapy. Moreover, the data provide further arguments to accept high costs of the BoNT/A treatment in these severely handicapped patients, as a consequence of its considerable benefit on quality of life.


Subject(s)
Botulinum Toxins, Type A/therapeutic use , Dystonic Disorders/drug therapy , Quality of Life , Aged , Female , Germany , Humans , Male , Middle Aged , Prospective Studies , Time Factors
14.
J Pineal Res ; 30(4): 213-9, 2001 May.
Article in English | MEDLINE | ID: mdl-11339510

ABSTRACT

We investigated regional L-3,4-dihydroxy-6-[18F]fluoro-phenyl-alanine (Fdopa) uptake within the pineal gland using co-registration of Fdopa PET and MRI images. Data from 12 early Parkinson's disease (PD) and 9 advanced PD patients were compared with those from 13 age-matched healthy controls. We found a significant increase of Fdopa influx constants (Ki) and relative Fdopa tracer activity in the pineal gland of PD patients. Additionally, significant correlations were found between Ki and the Hoehn and Yahr (H&Y) scores, and between the relative Fdopa activity and the parameters disease duration, H&Y disease score and Unified Parkinson's Disease Rating Scale (UPDRS). Our studies in patients with PD indicate a participation of extrastriatal dopaminergic structures within the scope of pathophysiological processes in PD. The result may be explained as a compensatory upregulation of monoaminergic transmitter systems outside the basal ganglia. Increased Fdopa uptake in the pineal gland may reflect pineal dysfunction in PD patients.


Subject(s)
Dihydroxyphenylalanine/pharmacokinetics , Parkinson Disease/diagnostic imaging , Parkinson Disease/metabolism , Pineal Gland/metabolism , Adult , Aromatic-L-Amino-Acid Decarboxylases/metabolism , Biological Transport, Active , Case-Control Studies , Dihydroxyphenylalanine/analogs & derivatives , Dihydroxyphenylalanine/metabolism , Female , Fluorine Radioisotopes , Humans , Magnetic Resonance Imaging , Male , Melatonin/physiology , Middle Aged , Parkinson Disease/physiopathology , Pineal Gland/diagnostic imaging , Pineal Gland/physiopathology , Tomography, Emission-Computed
15.
Ann Neurol ; 49(3): 367-76, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11261512

ABSTRACT

A kindred from South Tyrol (northern Italy) with familial, adult-onset parkinsonism of pseudo-dominant inheritance and mutations in the parkin gene was recently described. To gain insight into basal ganglia dysfunction in this form of hereditary parkinsonism, positron emission tomography (PET) with 18-fluorodopa (FDOPA) and 11C-raclopride (RAC) was performed in 5 affected family members and 5 asymptomatic relatives with proven compound heterozygous or heterozygous parkin mutations. Results were compared to findings in healthy control subjects and patients with typical sporadic, idiopathic Parkinson's disease. Similar to findings in the sporadic Parkinson's disease group, presynaptic striatal FDOPA storage was decreased in patients with compound heterozygous parkin mutations, with the most prominent reduction in the posterior part of the putamen. Along with the presynaptic lowered FDOPA uptake, we found a uniform reduction of the striatal 11C-raclopride binding index in all affected family members as compared to asymptomatic family members carrying a heterozygous parkin mutation, sporadic Parkinson's disease, and control subjects. Our PET data provide evidence that parkinsonism in this family is associated with presynaptic dopaminergic dysfunction similar to idiopathic Parkinson's disease pathophysiology, along with alterations at the postsynaptic D2 receptor level. In asymptomatic carriers of a single parkin mutation with an apparently normal allele, we found a mild but statistically significant decrease of mean FDOPA uptake compared to control subjects in all striatal regions. These data indicate a preclinical disease process in these subjects.


Subject(s)
Corpus Striatum/diagnostic imaging , Ligases/genetics , Parkinsonian Disorders/diagnostic imaging , Parkinsonian Disorders/genetics , Substantia Nigra/diagnostic imaging , Tomography, Emission-Computed , Adult , Aged , Analysis of Variance , Female , Humans , Male , Middle Aged , Mutation/genetics , Pedigree , Ubiquitin-Protein Ligases
16.
J Neural Transm (Vienna) ; 107(11): 1289-95, 2000.
Article in English | MEDLINE | ID: mdl-11145004

ABSTRACT

We report a case of a 74-year old woman who following an acute virus encephalitis developed an akinetic-rigid Parkinson syndrome with tremor, hypokinesia, hypomimia, rigidity and cogwheel phenomenon in all four extremities, brady-dysdiadochokinesia as well as myoclonic jerks of the arms. Many of the clinical features of this postencephalitic parkinsonism (PEP) suggested the diagnosis of sporadic encephalitis lethargica, first described by von Economo 1917. Cerebral spinal fluid showed signs of a viral encephalitis, and a positive influenza A IgA-antibody titer (1:>160) in the viral serologic screen was found. Positron emission tomography (PET) showed an altered pattern of glucose- and dopa-metabolism clearly different from findings in idiopathic Parkinson syndrome (IPS). The acute lack of inhibitory input from the substantia nigra pars compacta to the striatum could explain the different metabolic patterns in our case in comparison to IPS patients. Our findings indicate that PEP may also be caused by influenza A and furthermore that PET clearly distinguishes PEP from IPS.


Subject(s)
Dihydroxyphenylalanine/analogs & derivatives , Fluorodeoxyglucose F18 , Parkinson Disease, Postencephalitic/diagnostic imaging , Radiopharmaceuticals , Tomography, Emission-Computed , Aged , Diagnosis, Differential , Female , Humans , Magnetic Resonance Imaging , Parkinson Disease/diagnostic imaging , Parkinson Disease, Postencephalitic/diagnosis , Reference Values
17.
Clin Neurol Neurosurg ; 102(4): 210-214, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11154806

ABSTRACT

With the intention to assess remote effects of cerebellar dysfunction, 23 patients with inherited or idiopathic cerebellar ataxia were studied with positron emission tomography (PET) and 2[18F]fluoro-2-deoxy-D-glucose (FDG). Eight patients (group 1) suffered from early onset cerebellar ataxia (EOCA, age of symptom onset <20 years), nine patients (group 2) from late onset cerebellar ataxia (LOCA, symptom onset between the ages of 20 and 50), and six patients (group 3) experienced symptom onset beyond the age of 50 years. The pattern of cerebral glucose metabolism in cerebellar ataxia was compared to the results in a control group of 16 healthy subjects. In all patients, a reduction in relative (EOCA, group 1) or absolute (LOCA, groups 2 and 3) values of regional cerebral glucose metabolism (rCMR(glu)) occurred in both cerebellar hemispheres as well as the vermis and both dentate nuclei. In patients from all groups presenting with a clinical syndrome of pure cerebellar ataxia, impairment of regional glucose metabolism also extended to the pontine and brainstem regions. In contrast to this infratentorial reduction of rCMR(glu) in all patients, in those with LOCA, a significant relative increase in rCMR(glu) was present in distinct supratentorial cortical regions, namely the cuneus, the pre-cuneus and the gyrus supramarginalis in the patients of group 2. In group 3, this significant relative increase in rCMR(glu) was restricted to the cuneus. Thus, FDG-PET in patients suffering from cerebellar ataxia shows distinct patterns of altered glucose metabolism which exceed pure cerebellar impairment. Most importantly, FDG-PET yields insight into the influence of cerebellar disease on supratentorial glucose metabolism and documents impairment of supratentorial neuronal function with relative sparing of the parietal cortex.


Subject(s)
Cerebellar Ataxia/pathology , Glucose/metabolism , Parietal Lobe/physiology , Adult , Aged , Female , Fluorodeoxyglucose F18 , Humans , Male , Middle Aged , Parietal Lobe/pathology , Radiopharmaceuticals , Tomography, Emission-Computed
18.
Eur Psychiatry ; 14(6): 356-7, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10572371

ABSTRACT

The atypical antipsychotic drug olanzapine has been proposed for treatment of dopaminergic psychosis in Parkinson's disease (PD). We report on a 68-year-old patient who developed a severe akinetic-rigid extrapyramidal syndrome, accompanied by additional paranoid symptoms, following olanzapine treatment of optic hallucinosis in PD. Olanzapine may also induce clinically relevant extrapyramidal side effects in PD patients.


Subject(s)
Antiparkinson Agents/adverse effects , Antipsychotic Agents/adverse effects , Basal Ganglia Diseases/chemically induced , Hallucinations/chemically induced , Hallucinations/drug therapy , Levodopa/adverse effects , Parkinson Disease/drug therapy , Piperidines/adverse effects , Pirenzepine/analogs & derivatives , Selegiline/adverse effects , Aged , Basal Ganglia Diseases/complications , Basal Ganglia Diseases/diagnosis , Benzodiazepines , Clozapine/therapeutic use , Drug Therapy, Combination , Humans , Male , Olanzapine , Paranoid Disorders/complications , Paranoid Disorders/diagnosis , Paranoid Disorders/drug therapy , Pirenzepine/adverse effects , Severity of Illness Index
19.
Ann Neurol ; 45(4): 430-8, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10211466

ABSTRACT

As previous functional neuroimaging studies could not settle the controversy regarding the contribution of dominant and subdominant hemisphere to recovery from poststroke aphasia, language performance was related to H2(15)O-positron emission tomographic activation patterns in 23 right-handed aphasic patients 2 and 8 weeks after stroke. In patients classified according to the site of lesion (frontal, n = 7; subcortical, n = 9; temporal, n = 7) and in 11 control subjects, flow changes caused by a word repetition task were calculated in 14 regions representing eloquent and contralateral homotopic areas. These areas were defined on coregistered magnetic resonance imaging scans and tested for significance (Bonferroni corrected t test, alpha = 0.0036). At baseline, differences in test performance were only found between the subcortical and temporal group. The extent of recovery, however, differed and was reflected in the activation. The subcortical and frontal groups improved substantially; they activated the right inferior frontal gyrus and the right superior temporal gyrus (STG) at baseline and regained left STG activation at follow-up. The temporal group improved only in word comprehension; it activated the left Broca area and supplementary motor areas at baseline and the precentral gyrus bilaterally as well as the right STG at follow-up, but could not reactivate the left STG. These differential activation patterns suggest a hierarchy within the language-related network regarding effectiveness for improvement of aphasia; ie, right hemispheric areas contribute, if left hemispheric regions are destroyed. Efficient restoration of language is usually only achieved if left temporal areas are preserved and can be reintegrated into the functional network.


Subject(s)
Aphasia/physiopathology , Brain/diagnostic imaging , Brain/physiopathology , Functional Laterality/physiology , Adult , Aged , Aphasia/psychology , Brain Mapping , Cerebral Infarction/diagnostic imaging , Female , Humans , Male , Middle Aged , Neuropsychological Tests , Prognosis , Time Factors , Tomography, Emission-Computed
20.
J Neurosurg Anesthesiol ; 11(1): 17-24, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9890381

ABSTRACT

Regional cerebral glucose metabolism (rCMRglc) was investigated with 18F-2-fluoro-2-deoxy-D-glucose (FDG) and positron emission tomography (PET) in 24 patients with acute (AVS, duration <1 month, n=11) or persistent (PVS, duration >1 month, n=13) vegetative state (VS) following prolonged anoxia due to cardiorespiratory arrest. After a follow-up period of twelve months, 8 patients had died, 13 remained in a permanent vegetative state and three showed moderate improvement of consciousness, without however regaining independence for activities of daily life. As expected, overall glucose utilization (CMRglc) was significantly reduced in VS in comparison to age matched controls. Infratentorial structures showed a less distinct hypometabolism. Differences in metabolic rates between patients who died or remained in a PVS were small and insignificant and probably reflect different age structures of the two groups. A statistically significant correlation between the degree of evoked potential or EEG alterations in VS and the reduction of global or regional cortical metabolic rates for glucose could not be established. Cortical metabolic rates in patients with PVS were significantly reduced when compared to patients studied in AVS (p<0.05 for all cortical regions of interest except the frontal lobe). This phenomenon reflects the progressive loss of residual cortical function following anoxic brain injury that corresponds to the neuropathological findings of progressive Wallerian and transsynaptic degeneration as sequelae of anoxic brain injury in PVS.


Subject(s)
Brain/metabolism , Glucose/metabolism , Persistent Vegetative State/metabolism , Activities of Daily Living , Adolescent , Adult , Age Factors , Aged , Brain/diagnostic imaging , Case-Control Studies , Cerebellum/diagnostic imaging , Cerebellum/metabolism , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/metabolism , Consciousness/physiology , Electroencephalography , Evoked Potentials, Somatosensory/physiology , Female , Fluorodeoxyglucose F18 , Follow-Up Studies , Frontal Lobe/diagnostic imaging , Frontal Lobe/metabolism , Heart Arrest/complications , Humans , Hypoxia, Brain/diagnostic imaging , Hypoxia, Brain/etiology , Hypoxia, Brain/metabolism , Male , Middle Aged , Nerve Degeneration/metabolism , Nerve Degeneration/physiopathology , Persistent Vegetative State/diagnostic imaging , Persistent Vegetative State/physiopathology , Radiopharmaceuticals , Survival Rate , Tomography, Emission-Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...